Clinical impact of the metabolic phenotype of prostate cancer: role of monocarboxylate transporters (MCTs)

類似資料

• Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
  著者:: Nelma Pértega-Gomes, 等
  出版事項: (2014-10-01)
• Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know?
  著者:: Pértega-Gomes, Nelma, 等
  出版事項: (2014)
• Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
  著者:: Pértega-Gomes, Nelma, 等
  出版事項: (2011)
• Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
  著者:: Miranda-Gonçalves, Vera, 等
  出版事項: (2013)
• A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy
  著者:: Pertega‐Gomes, Nelma, 等
  出版事項: (2015)